Clinical trials: Fecal Incontinence
Faecal Incontinence, Prostate Cancer
Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with…
- Trial name
- NCT04262609
- Testing
- hypofractionated radiotherapy
- Where
- Spain
- Volunteers
- 200 people
- Sponsor
- Consorci Sanitari de Terrassa
Fecal Incontinence
The Use of an "Anal-Tape" in Patients With Fecal Incontinence
Fecal incontinence (FI), defined as the involuntary passage of stool for more than 3 months and is a devastating disease. The negative impact on quality of life has been consistently demonstrated.
- Trial name
- NCT02989545
- Testing
- Anal Tape
- Volunteers
- 20 people
- Sponsor
- Shaare Zedek Medical Center
Fecal Incontinence
Fat Grafting Technique for Fecal Incontinence
Fecal Incontinence affects an estimated 2-20% of the general population, and up to 50% of the elderly and institutionalized population.
- Trial name
- NCT03882632
- Testing
- Fat Grafting for Fecal Incontinence
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Melanie Salerno, RN
Fecal Incontinence
Clinical Use of a Magnetic Anal Sphincter Augmentation Device, Trade Name FENIX
This registration is for clinical use of the FENIX, a Humanitarian Use Device (HUD) for fecal incontinence. This device is indicated for the treatment of fecal incontinence in patients who are not candidates for or have…
- Trial name
- NCT02722707
- Testing
- magnetic anal sphincter augmentation for fecal incontinence
- Where
- 2 sites in United States
- Sponsor
- Mayo Clinic
Fecal Incontinence
EPIC :Anal Incontinence After Delivery. Secondary Prevention With Caesarean Section.
Anal incontinence is frequent and treatment is difficult. One of the most important reasons is traumatic delivery. 10 % of women develop anal incontinence after first delivery.
- Trial name
- EPIC (NCT00632567)
- Testing
- caesarean section, vaginal delivery
- Where
- France
- Volunteers
- 554 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Low Anterior Resection Syndrome (LARS>20), Refractory Medical Treatment After Rectal Resection
A Prospective Pilot Study to Assess the Efficacy of BOTOX-A in Patients With Low Anterior Resection Syndrome (LARS>20) and Refractory Medical Treatment After Rectal Resection
After rectal resection for cancer (with or without stoma), patients may have digestive sequelae. LARS (Low Anterior Resection Syndrome) includes bowel frequency, stool fragmentation, urgency, and faecal incontinence.
- Trial name
- BOTOX-TME (NCT04991688)
- Testing
- BOTOX-A
- Where
- France
- Volunteers
- 11 people
- Sponsor
- University Hospital, Bordeaux
Faecal Incontinence
Efficacy of Acupuncture as a Treatment for Faecal Incontinence
Overall Aim: To improve the long-term management outcomes for faecal incontinence (FI); through the implementation of new alternative treatment to complement existing treatment options, and enable better utilization of limited…
- Trial name
- NCT04276350
- Testing
- Acupuncture, Best Medical Therapy
- Where
- Singapore
- Volunteers
- 100 people
- Sponsor
- Singapore General Hospital
Perineum; Injury, Anal Incontinence
Efficacy of Antenatal Perineal Massage in Reducing Postpartum Morbidities
A randomized controlled trial was undertaken at Rajavithi Hospital, Bangkok, Thailand, encompassing 106 primigravidae within the period of December 2023 to June 2024.
- Conditions
- Perineum; Injury, Anal Incontinence, Urinary Incontinence
- Trial name
- NCT06162312
- Testing
- Antenatal perineal massage
- Where
- Thailand
- Volunteers
- 106 people, healthy volunteers welcome
- Sponsor
- Department of Medical Services Ministry of Public Health of Thailand
Fecal Incontinence
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Multi-center, prospective, within-subject control, open label clinical trial to evaluate the durability of the safety and effectiveness of the Eclipse™ System after 3 and 12 months of use.
- Trial name
- LIBERATE (NCT02428595)
- Testing
- Eclipse™ System
- Where
- 11 sites in United States
- Volunteers
- 137 people
- Sponsor
- Pelvalon, Inc.
Pelvic Floor Disorders, Urinary Incontinence
Effectiveness of Hypopressive Exercises Versus Pelvic-perineal Physiotherapy
Introduction: Hypopressive Exercises are included within a method of physiotherapy which was created with the purpose of strengthening the deep muscles of the abdomen without damaging ligamentous and muscular structures of the…
- Conditions
- Pelvic Floor Disorders, Urinary Incontinence, Fecal Incontinence, Pelvic Pain
- Trial name
- HEPFD (NCT02259712)
- Testing
- Hypopressive exercises, Therapeutic education., Pelvic-perineal physiotherapy
- Where
- Spain
- Volunteers
- 78 people
- Sponsor
- University of Alcala
Pelvic Floor Disorders, Obstetric Trauma
Correlation Pelvic Floor Function and Ultrasound Findings One Year After Childbirth
This is a single-center prospective cohort study sponsored by the University Hospitals Leuven (UZ). Women will undergo a pelvic floor ultrasound and will be asked to fill out a questionnaire at the time of their admission into…
- Conditions
- Pelvic Floor Disorders, Obstetric Trauma, Urinary Incontinence, Anal Incontinence
- Trial name
- DeliverUU (NCT05530681)
- Testing
- Questionnaire, Pelvic floor ultrasound
- Where
- Belgium
- Volunteers
- 320 people
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
Body Image, Urinary Incontinence
Pelvic Floor Dysfunction and Its Influence on Body Image and Sexual Function
The first objective to determinate the prevalence of pelvic floor dysfunction in pregnant women and in the first year postpartum.
- Conditions
- Body Image, Urinary Incontinence, Anal Incontinence, Anorectal Disorder
- Trial name
- PFD-BI (NCT03591393)
- Testing
- questionnaire
- Where
- Belgium
- Volunteers
- 328 people, healthy volunteers welcome
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
Faecal Incontinence, Faecal Incontinence With Faecal Urgency
Acs-Tens Treatment for Faecal Incontinence: a RCT With Sham-controls
This study assess the effectiveness on AcuTENS on the treatment of faecal incontinence
- Conditions
- Faecal Incontinence, Faecal Incontinence With Faecal Urgency, Neuromodulation, Transcutaneous Electric Nerve Stimulation
- Trial name
- NCT04749316
- Testing
- AcuTENS
- Where
- Hong Kong
- Volunteers
- 53 people
- Sponsor
- Chinese University of Hong Kong
Constipation
Biofeedback for Dyssynergic Constipation
Constipation affects 4% of adults in the United States (U.S.). An estimated half of constipated patients are unable to relax pelvic floor muscles during defecation, a type of constipation called pelvic floor dyssynergia (PFD).
- Trial name
- NCT00127257
- Testing
- Biofeedback, Diazepam, Pelvic floor retraining
- Where
- United States
- Volunteers
- 117 people
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Anal Incontinence
Does the Negativation of the Glucose Hydrogen Breath Test Come Along With a Reduction of the Symptoms of Gaz Incontinence ?
The objectives of this work are: 1/to estimate the frequency of a positive glucose breath test in favour of a small intestinal bacterial overgrowth in a population of patients consulting for gaz incontinence by comparison to a…
- Trial name
- NCT01275560
- Testing
- Metronidazole, CArbosylane
- Where
- France
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- University Hospital, Rouen
Faecal Incontinence
Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days
The study is being conducted to evaluate the safety and tolerability after single and repeated twice daily intra-anal applications of 1mL NRL001 cream in stepwise increasing concentrations.
- Trial name
- NCT06593730
- Testing
- NRL001 cream 0.5%w/w, NRL001 cream 0.75%w/w, NRL001 cream 1.0%w/w
- Volunteers
- 72 people, healthy volunteers welcome
- Sponsor
- Norgine
Obstetric Anal Sphincter Injury
Postpartum Health Trajectories the First Year After Obstetric Anal Sphincter Injury and the Impact of a Group-Based Intervention
The aim of the ADAPT study is to investigate whether a structured, group-based follow-up programme can improve quality of life related to anal incontinence in women with OASI during the first year after childbirth.
- Trial name
- ADAPT (NCT07667660)
- Testing
- Group Session
- Where
- Denmark
- Volunteers
- 110 people
- Sponsor
- Hanna Jangö
Fecal Incontinence
Treatment of Patients With Fecal Incontinence
The purpose of this study is to determine if a behavioral treatment method called biofeedback will reduce the frequency of episodes of leakage of fecal material in patient suffering from fecal incontinence.
- Trial name
- NCT00292318
- Testing
- Biofeedback Therapy for Fecal Incontinence: A Randomized Control Study, control group
- Where
- United States
- Volunteers
- 7 people
- Sponsor
- US Department of Veterans Affairs
Spina Bifida
Retrograde Colonic Irrigation to Manage Spina Bifida Functional Digestive Sequelae: a Multicenter, Prospective, Randomized Controlled Trial
Spina Bifida is a developmental congenital disorder caused by the incomplete closing of the embryonic neural tube, leading to serious malformations of the nervous system.
- Trial name
- IRRICO (NCT02361450)
- Testing
- Retrograde Colonic Irrigation, Usual Care
- Where
- 6 sites in France
- Volunteers
- 34 people
- Sponsor
- Rennes University Hospital
Fecal Incontinence in Children
Biofeedback Training Fecal Incontinence in Children
Fecal incontinence (FI) is the inability to control bowel movements, causing stool to leak from rectum it ranges from an occasional leakage of stool while passing gas to a complete loss of bowel control after the age of 4 years1.
- Trial name
- NCT04472923
- Testing
- Traditional Treatment, Biofeedback
- Where
- Egypt
- Volunteers
- 108 people
- Sponsor
- Batterjee Medical College